Collectively, literature indicates the activation of inflammasomes and release of IL-1β chemokines as pivotal underlying factors in the development of insulin resistance, which could be an explanation why the overexpression of Ch25h resulted in lower glucose and insulin levels and improved insulin sensitivity. The gene discussed is CH25H; the disease is Insulin resistance.